Multidetector CT predictors of incomplete resection in primary cytoreduction of patients with advanced ovarian cancer

European Radiology

Volumn 20, Issue 1, 2010, Pages 100-107

  Jung, Dae Chul ^a   Kang, Sokbom ^a   Kim, Min Ju ^a   Park, Sang Yoon ^a   Kim, Hyun Beom ^a  

^a National Cancer Center   (South Korea)

Author keywords

Cancer; Cytoreduction; MDCT; Ovary; Predictor

Indexed keywords

ABDOMINAL TUMOR; ADULT; ADVANCED CANCER; ARTICLE; ASCITES; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; OVARIECTOMY; OVARY CANCER; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PROGNOSIS; RADIOGRAPHIC IMAGE ENHANCEMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 76949091752     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1533-0     Document Type: Article

References (46)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66 10.3322/canjclin.57.1.43 17237035
2. JA Spencer 2005 A multidisciplinary approach to ovarian cancer at diagnosis Br J Radiol 78 Spec No. 2 S94 S102 10.1259/bjr/29280555 16306641 (Pubitemid 43019917)
3. SA Cannistra 2004 Cancer of the ovary N Engl J Med 351 2519 2529 10.1056/NEJMra041842 1:CAS:528:DC%2BD2cXhtVGksbbM 15590954 (Pubitemid 39603165)
4. RE Bristow RS Tomacruz DK Armstrong EL Trimble FJ Montz 2002 Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 1248 1259 10.1200/JCO.20.5. 1248 11870167 (Pubitemid 34177431)
5. DS Chi JB Liu LF Leon ES Venkatraman ML Hensley D Bhaskaran WJ Hoskins 2001 Identification of prognostic factors in advanced epithelial ovarian carcinoma Gynecol Oncol 82 532 537 10.1006/gyno.2001.6328 1:STN:280: DC%2BD3Mvnslagtg%3D%3D 11520151 (Pubitemid 32826455)
6. SM Eisenkop NM Spirtos 2001 What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating epithelial ovarian cancer Gynecol Oncol 82 489 497 10.1006/gyno.2001.6312 1:STN:280:DC%2BD3Mvnslahug%3D%3D 11520145 (Pubitemid 32826449)
7. WJ Hoskins WP McGuire MF Brady, et al. 1994 The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am J Obstet Gynecol 170 974 979 1:STN:280:DyaK2c3hvFGntQ%3D%3D 8166218
8. WJ Hoskins 1994 Epithelial ovarian carcinoma: principles of primary surgery Gynecol Oncol 55 S91 S96 10.1006/gyno.1994.1346 1:STN:280: DyaK2M7jslGjuw%3D%3D 7835815
9. GD Aletti BS Gostout KC Podratz WA Cliby 2006 Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon Gynecol Oncol 100 33 37 10.1016/j.ygyno.2005.07.123 16153692 (Pubitemid 41815046)
10. DS Chi CC Franklin DA Levine, et al. 2004 Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol 94 650 654 10.1016/j.ygyno.2004.01.029 15350354 (Pubitemid 39194456)
11. Holschneider CH, Berek JS (2005) Cytoreductive surgery: Principles and rationale. In: Bristow RE, Karlan BY, Montz FJ (eds) Surgery for ovarian cancer: principles and practice. Parthenon, Lancaster, pp 141-143
12. S Risum C Hogdall A Loft, et al. 2008 Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study Gynecol Oncol 108 265 270 10.1016/j.ygyno.2007.11.002 1:STN:280:DC%2BD1c%2FovV2nsg%3D%3D 18055006 (Pubitemid 351181445)
13. EL Eisenhauer NR Abu-Rustum YA Sonoda C ghajanian RR Barakat DS Chi 2008 The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer Gynecol Oncol 108 276 281 10.1016/j.ygyno.2007.10.022 1:CAS:528: DC%2BD1cXhtlOqsbs%3D 18063020
14. S Kawamoto BA Urban EK Fishman 1999 CT of epithelial ovarian tumors Radiographics 19 S85 S102 10517447
15. R Forstner H Hricak S White 1995 CT and MRI of ovarian cancer Abdom Imaging 20 2 8 10.1007/BF00199633 1:STN:280:DyaK2M3gtFGqsA%3D%3D 7894290
16. AE Bland EN Ecerett LM Pastore WA Andersen PT Taylor Jr 2008 Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy Int J Gynecol Cancer 18 629 636 10.1111/j.1525-1438.2007.01114.x 1:STN:280:DC%2BD1crisl2rsQ%3D%3D 17986246 (Pubitemid 352020188)
17. DS Chi PE Schwartz 2008 Cytoreduction vs neoadjuvant chemotherapy for ovarian cancer Gynecol Oncol 111 391 399 10.1016/j.ygyno.2008.07.058 19041036
18. A Qayyum FV Coakley AC Westphalen H Hricak WT Okuno B Powell 2005 Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer Gynecol Oncol 96 301 306 10.1016/j.ygyno.2004. 06.054 15661212 (Pubitemid 40127125)
19. CM Tempany KH Zou SG Silverman DL Brown AB Kurtz BJ McNeil 2000 Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group Radiology 215 761 767 1:STN:280:DC%2BD3c3ptlCntg%3D%3D 10831697
20. HK Pannu KM Horton EK Fishman 2003 Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers J Comput Assist Tomogr 27 333 340 10.1097/00004728- 200305000-00006 12794595 (Pubitemid 36798083)
21. AE Axtell MH Lee RE Bristow SC Dowdy, et al. 2007 Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer J Clin Oncol 5 384 389 10.1200/JCO.2006.07.7800 (Pubitemid 350002986)
22. RE Bristow LR Duska NC Lambrou EK Fishman MJ O'Neill EL Trimble FJ Montz 2000 A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 1532 1540 10.1002/1097- 0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A 1:STN:280: DC%2BD3cvmslSktQ%3D%3D 11013368 (Pubitemid 30727220)
23. R Salani A Axtell M Gerardi C Holschneider RE Bristow 2008 Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer Gynecol Oncol 108 271 275 10.1016/j.ygyno.2007.11.004 18164380
24. GA Omura MF Brady HD Homesley E Yordan FJ Major HJ Buchsbaum RC Park 1991 Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience J Clin Oncol 9 1138 1150 1:STN:280:DyaK3M3lvFWlsQ%3D%3D 1904477
25. AP Makar M Baekelandt CG Trope GB Kristensen 1995 The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer Gynecol Oncol 56 175 180 10.1006/gyno.1995.1027 1:STN:280:DyaK2M3gtlOluw%3D%3D 7896181
26. T Le GV Krepart RJ Lotocki MS Heywood 1997 Does debulking surgery improve survival in biologically aggressive ovarian carcinoma Gynecol Oncol 67 208 214 10.1006/gyno.1997.4839 1:STN:280:DyaK1c%2FjsFymuw%3D%3D 9367710 (Pubitemid 27500422)
27. SM Eisenkop RL Friedman HJ Wang 1998 Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study Gynecol Oncol 69 103 108 10.1006/gyno.1998.4955 1:STN:280:DyaK1c3mtlajuw%3D%3D 9600815 (Pubitemid 28246994)
28. RE Bristow FJ Montz 2001 Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator Gynecol Oncol 83 39 48 10.1006/gyno.2001.6344 1:STN:280:DC%2BD3MrjvV2ktg%3D%3D 11585412 (Pubitemid 32959877)
29. SM Eisenkop NM Spirtos RL Friedman WC Lin AL Pisani S Perticucci 2003 Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study Gynecol Oncol 90 390 396 10.1016/S0090-8258(03)00278-6 12893206 (Pubitemid 36952033)
30. DS Chi EL Eisenhauer J Lang, et al. 2006 What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC) Gynecol Oncol 103 559 564 10.1016/j.ygyno.2006.03.051 1:STN:280: DC%2BD28nktFCmug%3D%3D 16714056 (Pubitemid 44602167)
31. S Mironov O Akin N Pandit-Taskar LE Hann 2007 Ovarian cancer Radiol Clin North Am 45 149 166 10.1016/j.rcl.2006.10.012 17157627 (Pubitemid 44854050)
32. MA Meyers 1970 The spread and localization of acute intraperitoneal effusions Radiology 95 547 554 1:STN:280:DyaE3c7nvV2jsw%3D%3D 5442658
33. MA Meyers 1975 Metastatic seeding along the small bowel mesentery. Roentgen features Am J Roentgenol 123 67 73 1:STN:280:DyaE2M7is1WktQ%3D%3D
34. SC Dowdy SA Mullany KR Brandt BJ Huppert WA Cliby 2004 The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma Cancer 101 346 352 10.1002/cncr.20376 15241833 (Pubitemid 38890839)
35. EN Everett CC Heuser LM Pastore WA Anderson LW Rice WP Irvin PT Taylor 2005 Predictors of suboptimal surgical cytoreduction in women treated with initial cytoreductive surgery for advanced stage epithelial ovarian cancer Am J Obstet Gynecol 193 568 574 10.1016/j.ajog.2005.03.058 16098898 (Pubitemid 41159557)
36. HL Kundel M Polansky 2003 Measurement of observer agreement Radiology 228 303 308 10.1148/radiol.2282011860 12819342 (Pubitemid 36910064)
37. EN Everett AE French RL Stone LM Pastore AA Jazaeri WA Andersen PT Taylor Jr 2006 Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer Am J Obstet Gynecol 195 568 576 10.1016/j.ajog.2006.03.075 16890558 (Pubitemid 44142391)
38. BE Nelson AT Rosenfield PE Schwartz 1993 Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma J Clin Oncol 11 166 172 1:STN:280:DyaK3s7hsFOltQ%3D%3D 8418230
39. JI Meyer AW Kennedy R Friedman A Ayoub RC Zepp 1995 Ovarian carcinoma: value of CT in predicting success of debulking surgery AJR Am J Roentgenol 165 875 878 1:STN:280:DyaK2MvgslClsw%3D%3D 7676985
40. DS Chi CC Franklin DA Levine F Akselrod P Sabbatini WR Jarnagin 2004 DeMatteo R, Poynor EA, Abu-Rustum NR, Barakat RR, Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol Oncol 94 650 654 10.1016/j.ygyno.2004.01.029 15350354 (Pubitemid 39194456)
41. S Bhoola WJ Hoskins 2006 Diagnosis and management of epithelial ovarian cancer Obstet Gynecol 107 1399 1410 16738170
42. JS Berek NF Hacker LD Lagasse RK Nieberg RM Elashoff 1983 Survival of patients following secondary cytoreductive surgery in ovarian cancer Obstet Gynecol 61 189 193 1:STN:280:DyaL3s7hs1Sntw%3D%3D 6823360
43. K Bertelsen 1990 Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study Gynecol Oncol 38 203 209 10.1016/0090-8258(90)90042-J 1:STN:280:DyaK3czltlygsw%3D%3D 2167280 (Pubitemid 20258596)
44. PE Colombo A Mourregot M Fabbro, et al. 2009 Aggressive surgical strategies in advanced ovarian cancer: A monocentric study of 203 stage IIIC and IV patients Eur J Surg Oncol 35 135 143 18289825
45. J Huober A Meyer U Wagner D Wallwiener 2002 The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer J Cancer Res Clin Oncol 128 153 160 10.1007/s00432-001-0312-3 1:CAS:528:DC%2BD38XhsVCgs7g%3D 11935302 (Pubitemid 34185638)
46. F Carnino G Fuda G Ciccone L Iskra E Guercio D Dadone PF Conte 1997 Significance of lymph node sampling in epithelial carcinoma of the ovary Gynecol Oncol 65 467 472 10.1006/gyno.1997.4633 1:STN:280:DyaK2szjsVarsg%3D%3D 9190977 (Pubitemid 27255990)